Table 2.
Biological data at T0
| Biological data | Patients with SAKI (n = 42) |
|---|---|
| MAP (mm Hg) | 67.2 ± 32.5 |
| PaO2/FiO2 | 192 (131, 352) |
| SOFA | 10 ± 3 |
| APACHE II | 18 (14, 21) |
| WBC count (×109/L) | 14.5 (11.3, 18.9) |
| Hct (%) | 25.0 ± 5.3 |
| PLT (×109/L) | 98 (46, 219) |
| CRP (mg/dL) | 146.7 (53.3, 189.9) |
| PCT (ng/mL) | 13.21 (3.02, 38.81) |
| SCr (μmol/L) | 242 (189, 367) |
| BUN (mmol/L) | 12.3 ± 8.4 |
| Fibrinogen (g/L) | 5.9 ± 3.2 |
| Albumin (g/L) | 28 ± 7.5 |
| Lactate (mmol/L) | 5.4 (2.2, 7.6) |
Normally distributed quantitative data are presented as mean ± SD. Non-normally distributed quantitative data are presented as median (25th, 75th percentiles). Qualitative data are presented as n (%). APACHE II acute physiology and chronic health evaluation II, BUN blood urea nitrogen, COPD chronic obstructive pulmonary disease, CRP C-reactive protein, Hct hematocrit, MAP mean arterial pressure, PCT procalcitonin, PLT platelets, SAKI septic acute kidney injury, SOFA sequential organ failure assessment, SCr serum creatinine, WBC white blood cell